What's Hot

View all perspectives
      Abatacept: is there a role before RA hits?
      1 year 4 months ago
      RT @synovialjoints: JAKi use did not increase CV risk compared to TNF, no difference between Bari and Tofa, non signific

      Dr. Antoni Chan synovialjoints

      1 year 4 months ago
      JAKi use did not increase CV risk compared to TNF, no difference between Bari and Tofa, non significant increased IRR in patients >65 years, Merel Opdam, Abst#OP0221 #EULAR2023 @RheumNow https://t.co/Pu5X8RHJOY
      RT @bella_mehta: #Deeplearning in salivary biopsies in #SjogrensSyndrome - 327 pts - binary focus score (>=1) predict

      Bella Mehta bella_mehta

      1 year 4 months ago
      #Deeplearning in salivary biopsies in #SjogrensSyndrome - 327 pts - binary focus score (>=1) prediction the AUROC was 0.87 and for primary sjogrens diagnosis prediction it was 0.84 Quicker and cost effective in the future? @rheumnow #EULAR2023 abst#OP0232 https://t.co/Ec0zuKqpXf
      RT @drdavidliew: So we need protocolized extra steroids in new RA? A debate as old as time

      Individual patient data meta

      David Liew drdavidliew

      1 year 4 months ago
      So we need protocolized extra steroids in new RA? A debate as old as time Individual patient data metaanalysis - slight gains early on, not sustained - fewer DMARD changes - but a heap more PNL, well after the protocol ends Life is about trade-offs😐 OP0220 #EULAR2023 @RheumNow https://t.co/M8SBKjGncv
      RT @Yuz6Yusof: #EULAR2023 #POS1066 “Diagnosis: Seropositive Nodular Rheumatoid Arthritis” - I can probably get rid o

      Md Yuzaiful Md Yusof Yuz6Yusof

      1 year 4 months ago
      #EULAR2023 #POS1066 “Diagnosis: Seropositive Nodular Rheumatoid Arthritis” - I can probably get rid of Nodular soon in my letter. Trends of Nodules have decreased over time. Could be because we are getting better at preventing erosion and smoking cessation @RheumNow https://t.co/fmQvyNHCUJ
      RT @AurelieRheumo: Impact of menopause & on function in RA

      HAQ increases slightly after menopause

      Premature menopa

      Aurelie Najm AurelieRheumo

      1 year 4 months ago
      Impact of menopause & on function in RA HAQ increases slightly after menopause Premature menopause = worse function Slightly better HAQ (but moderate & no effects on other PROs) in THR group vs. non THR No safety data @RheumNow OP0268 #EULAR23 https://t.co/7KJScF8O2X
      RT @Janetbirdope: Risks for #ILD #SSc lung progression. FVC decline >5% is the gold standard but there are other crit

      Janet Pope Janetbirdope

      1 year 4 months ago
      Risks for #ILD #SSc lung progression. FVC decline >5% is the gold standard but there are other criteria. OP0236 #EULAR2023 @RheumNow @eular_org #scleroderma Some criteria are stricter - larger PFT changes and/or worsening symptoms or fibrosis, so depends on def’n for % def’n https://t.co/TCuX2KY64w
      RT @Janetbirdope: #Scleroderma activity index #SCTC has an initial validated tool that is associated with death and orga

      Janet Pope Janetbirdope

      1 year 4 months ago
      #Scleroderma activity index #SCTC has an initial validated tool that is associated with death and organ damage with moderate correlations, so it has some degree of face validity ⁌@RheumNow⁊ #EULAR2023 ⁌@eular_org⁊ #OP0235 https://t.co/RDekhr7d2e
      RT @synovialjoints: Initial use of glucocorticoids GC as bridging treatment in RA resulted in increase use of GC later,

      Dr. Antoni Chan synovialjoints

      1 year 4 months ago
      Initial use of glucocorticoids GC as bridging treatment in RA resulted in increase use of GC later, fewer DMARD changes later, van Ouwerkek L, Abst#OP220 #EULAR2023 @RheumNow https://t.co/IjxgQTZ8SE
      RT @bella_mehta: >= 2 tophi and carotid plaque by ultrasound could independently predict major adverse cardiovascular

      Bella Mehta bella_mehta

      1 year 4 months ago
      >= 2 tophi and carotid plaque by ultrasound could independently predict major adverse cardiovascular events in addition to conventional CVD risk factors in #gout, data from a single center cohort of 262 pts with 10 yr follow up #EULAR2023 @rheumnow abst#OP0154
      RT @drdavidliew: Malignancy in real world datasets:
      do we see differences between DMARDs - particularly JAKi, with ORAL

      David Liew drdavidliew

      1 year 4 months ago
      Malignancy in real world datasets: do we see differences between DMARDs - particularly JAKi, with ORAL Surveillance in mind? RABBIT German data (limited risk window): Point estimates slightly up vs TNFi, esp in high CV risk pts but magnitude not big OP0218 #EULAR2023 @RheumNow https://t.co/Ou7TgWvf3b
      RT @Janetbirdope: Scleroderma has an activity index that is associated w future morbidity & mortality. I wonder re t

      Janet Pope Janetbirdope

      1 year 4 months ago
      Scleroderma has an activity index that is associated w future morbidity & mortality. I wonder re the weightings of diff clinical manifestations as scleroderma renal crisis could weigh similarly to ex elevated CRP & a less severe manifestation. OP0235 @RheumNow #EULAR2023 https://t.co/KkimHBDVpg
      RT @Janetbirdope: #ClinicalPearl Updated #scleroderma Rx recommendations OP0234 New recommendations included ILD, early

      Janet Pope Janetbirdope

      1 year 4 months ago
      #ClinicalPearl Updated #scleroderma Rx recommendations OP0234 New recommendations included ILD, early dcSSc 20 vs prior 16 guidelines. And they recommend ??! Won’t release yet due to importance of wording which will be finalized soon EULAR2023 @RheumNow @eular_org https://t.co/lES6pqkgeT
      RT @synovialjoints: The JAK-pot study did not show any significant differences in MACE and other CV outcomes in RA patie

      Dr. Antoni Chan synovialjoints

      1 year 4 months ago
      The JAK-pot study did not show any significant differences in MACE and other CV outcomes in RA patients treated with JAKi, slight increase signal in VTE/PE, Romain Aymon, Abst#OP0219 #EULAR2023 @RheumNow https://t.co/oPMnw2QmW3
      RT @Yuz6Yusof: #EULAR2023 POS1190-HPR Besides genetic influence, what do patients with #SLE think re: cause of the disea

      Md Yuzaiful Md Yusof Yuz6Yusof

      1 year 4 months ago
      #EULAR2023 POS1190-HPR Besides genetic influence, what do patients with #SLE think re: cause of the disease? A survey in N=290 in Sweden showed stress, hormones & infection as the next top 3 causes. Those reported the first two had different education & perceived health @RheumNow https://t.co/GhyCyp7EWU

      Podcasts

      • ANA+ Consult (10.18.2024)
      • Dot The I, Cross The T (10.11.2024)
      • Stop Counting Bugs (10.4.2024)

      Catch up on Conference Podcasts

      Key Conference Topics

      Additional Topics

      Filter by Type

      Featured Video

      Do you get our email newsletter?

      Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

      Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

      Copyright {{ 'now'|date('Y') }} All Rights Reserved.